Biofrontera (BFRI) Other financing activities (2021 - 2022)
Biofrontera (BFRI) posted quarterly Other financing activities of $4.8 million for Q4 2022, down 66.84% year-over-year from $14.4 million in Q4 2021, and up 200.0% quarter-over-quarter from -$4.8 million in Q3 2022.
Biofrontera (BFRI) Other financing activities (2021 - 2022) Analysis & Trends
Biofrontera's Other financing activities history runs 2 years deep, the most recent figure standing at $4.8 million for Q4 2022.
- In Q4 2022, Other financing activities fell 66.84% year-over-year to $4.8 million; the TTM figure through Dec 2022 stood at $23.7 million (changed N/A YoY), while the FY2022 annual figure was $9.4 million, down 37.37% from the prior year.
- Other financing activities for Q4 2022 stood at $4.8 million, up from -$4.8 million in the prior quarter.
- The five-year high for Other financing activities was $14.4 million in Q4 2021, with the low at -$4.8 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Biofrontera | 19.06 Mn | 14.35 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 4.76 Mn |
| Dec 31, 2022 | 4.76 Mn |
| Sep 30, 2022 | -4.76 Mn |
| Sep 30, 2022 | -4.76 Mn |
| Jun 30, 2022 | 9.39 Mn |
| Jun 30, 2022 | 9.39 Mn |
| Dec 31, 2021 | 14.36 Mn |
| Dec 31, 2021 | 14.36 Mn |
| Sep 30, 2021 | 121,000.00 |
| Sep 30, 2021 | 121,000.00 |